Join Dr. Kirk R. Schultz from the University of British Columbia as he discusses new and emerging therapies in cGvHD.  In this 20 min. presentation, he focuses on the future directions of treatment for cGvHD, including the idea of synergistic therapy and how biomarkers may be used to personalize therapy.